Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

St. John's wort trial

This article was originally published in The Tan Sheet

Executive Summary

Affected by a suspension in enrollment of human subjects in all Duke University trials mandated by HHS' Office for Protection from Research Risks. The study is funded by National Institute of Mental Health and NIH Center for Complementary and Alternative Medicine. The suspension, which Duke expects to be temporary, results from OPRR-identified problems with Duke Institutional Review Board "administrative procedures governing the review of research proposals." Duke says the "action is not due to improper care of research participants and does not affect ongoing research that offers therapeutic benefits to patients"
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS089829

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel